GS-441524 is the main plasma metabolite of the antiviral prodrug RDV, and has a half-life of around 24 hours in human patients. RDV and GS-441524 were both found to be effective in vitro against feline coronavirus strains responsible for feline infectious peritonitis (FIP), a lethal systemic disease affecting domestic cats.
| Attributes | Details |
|---|---|
| Product Name | GS-441524 Tablets |
| Storage | Store At 2°C To 20°C |
| Grade | Pharmaceutcial Grade |
| Active Ingredient | GS-441524 |
| CAS | 1191237-69-0 |
| Form | Tablets |
| Specification | 20mg/tablets, 40mg/tablets, Or Customized |
| Packaging | 10 Tablets Per Bag |
| 12 months | 12 Months |
| Route of Administration | Intramuscular Or Subcutaneous |